Aska Pharmaceutical Holdings Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Aska Pharmaceutical Holdings Co., Ltd.

Aska Pharmaceutical Holdings Co., Ltd. (あすか製薬ホールディングス株式会社, 4886), Pharmaceutical. 21 cross-shareholdings, a board of 13 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YEAY, filed 2026-06-19. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-3156.64.383.3151.2215.00777
2023-03-3160.54.287.1150.0816.00747
2024-03-3162.87.590.7266.5140.00762
2025-03-3164.15.1104.3179.9555.001,632
2026-03-3171.15.4112.4191.1260.001,611

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Mitsubishi UFJ Financial Group, Inc.1,193,8543.10.0
OSAKA SODA CO., LTD.1,230,0002.11.0
Inabata & Co.,Ltd.393,3001.60.7
ZERIA PHARMACEUTICAL CO., LTD.374,0000.80.8
Mebuki Financial Group,Inc.620,1000.70.1
Iyogin Holdings, Inc.194,8750.60.1
TODA CORPORATION282,2000.40.1
The Toho Bank, Ltd.600,0000.40.2
Takeda Pharmaceutical Company Limited50,0000.30.0
DAIKIN INDUSTRIES,LTD.8,8000.20.0

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown